Mobile

A proof of concept study of the effects of QAX576 (an interleukin-13 monoclonal antibody) on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with se...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-003403-13

A proof of concept study of the effects of QAX576 (an interleukin-13 monoclonal antibody) on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the ability of QAX576 to inhibit inflammation from nasal allergen exposure (Timothy Grass Pollen) as assessed by Th2-associated cytokines in nasal secretions.

Critère d'inclusion

  • Seasonal Allergic Rhinitis

Liens